title: Treatment of chronic hepatitis C in individuals with pre-existing or confounding neuropsychiatric disease.
abstract: The problems associated with the recognition and management of chronic hepatitis C in a population of individuals with confounding psychiatric disease are identified. The experience of treating such patients and the psychotropic medication required during treatment are reviewed.
authors.affiliation: Department of Medicine, University of Kentucky School of Medicine, Lexington 40536, USA.
authors.forename: D H
authors.initials: DH
authors.lastname: Van Thiel
authors.forename: L
authors.initials: L
authors.lastname: Friedlander
authors.forename: N
authors.initials: N
authors.lastname: De Maria
authors.forename: P J
authors.initials: PJ
authors.lastname: Molloy
authors.forename: R J
authors.initials: RJ
authors.lastname: Kania
authors.forename: A
authors.initials: A
authors.lastname: Colantoni
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000453:epidemiology / Q000523:psychology* / Q000628:therapy*; D006801:Humans; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy / Q000453:epidemiology*; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors
chemical_list: D000998:Antiviral Agents; D011619:Psychotropic Drugs; D007372:Interferons